stockrowIRIDEX Corporation
IRIX Healthcare Medical Devices
IRIDEX Corporation’s revenue for fiscal 2025 (year ended December 2025) was $52.7 million, up 8.23% from fiscal 2024.
- Revenue
- −7.41%
- EPS
- −16.7%
- Free cash flow
- +130.2%
- Total debt
- +3.27%
Quarter to June 2026, against a year earlier
Follow IRIX
Alert me
IRIDEX Corporation (IRIX) EV/Sales
As of 6 November 2026, IRIDEX Corporation (IRIX) trades at a EV/Sales of 0.2×. Over the past ten years it has ranged from 0.2× (September 2019) to 3.4× (November 2016); the current reading is higher than 1% of that period. That is below the Medical Devices industry median of 2.8× and below the Healthcare sector median of 3.6×.
EV/Sales, daily
Embed this chart
Annual newest first
| Period | EV/Sales | Change |
|---|---|---|
| FY2025 | 0.4× | (38.07%) |
| FY2024 | 0.6× | (29.28%) |
| FY2023 | 0.8× | 123.86% |
| FY2022 | 0.4× | (73.21%) |
| FY2021 | 1.4× | 92.25% |
| FY2020 | 0.7× | 44.94% |
| FY2019 | 0.5× | (42.69%) |
| FY2018 | 0.8× | (49.78%) |
| FY2017 | 1.7× | (33.43%) |
| FY2016 | 2.5× | 28.38% |
Quarterly newest first
| Period | EV/Sales | Change |
|---|---|---|
| Jun 2026 | 0.4× | 15.78% |
| Mar 2026 | 0.3× | (1.74%) |
| Dec 2025 | 0.4× | (6.39%) |
| Sep 2025 | 0.4× | 41.02% |
| 42 more quarters | Free account |
Against its own ten years
EV/Sales against peers
| Company | EV/Sales |
|---|---|
| MODD Modular Medical, Inc. compare | n/m |
| ITOC iTonic Holdings Ltd. compare | n/m |
| RBOT Vicarious Surgical Inc. compare | n/m |
| IRIX IRIDEX Corporation | 0.2× |
| BTCY Biotricity Inc. compare | 1.7× |
| SINT SINTX TECHNOLOGIES, INC. compare | 2.6× |
| PETV PetVivo Holdings, Inc. compare | 19.7× |
| PAVM PAVmed Inc. compare | 189× |
| HSCS HeartSciences Inc. compare | 519× |
| Medical Devices industry median | 2.8× |
| Healthcare sector median | 3.6× |
| Market median | 2.1× |
What EV/Sales is
EV/Sales tells an investor how the value of a whole company, counting its debt and cash, compares with the sales it brings in.
((Stock Price × Shares (Basic, Weighted) (latest quarter)) + (Long Term Debt (Total) (latest quarter) + Current Part of Debt (latest quarter)) − Cash & Short Term Investments (latest quarter)) ÷ Revenue (TTM)